Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteogenesis imperfecta.

R Smith

    Clinics in Rheumatic Diseases
    |December 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Brittle bone syndrome, or osteogenesis imperfecta, is caused by mutations in type I collagen. Advances in biochemical knowledge aid prenatal diagnosis, but clinical care for severe cases remains a challenge.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Paget's disease of bone.

    BMJ (Clinical research ed.)·1992
    Same author

    Nonuniform expression of a mouse mammary tumor virus-driven int-2/Fgf-3 transgene in pregnancy-responsive breast tumors.

    Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research·1992
    Same author

    Proviral insertions near cyclin D1 in mouse lymphomas: a parallel for BCL1 translocations in human B-cell neoplasms.

    Oncogene·1992
    Same author

    Beta-endrophin immunoreactivity during human pregnancy.

    The Journal of clinical endocrinology and metabolism·1992
    Same author

    Whistle blowing: a curse on ineffective organisations.

    BMJ (Clinical research ed.)·1992
    Same author

    Using a mock trial to make a difficult clinical decision.

    BMJ (Clinical research ed.)·1992
    Same journal

    Metabolic and endocrine aspects of rheumatic disease.

    Clinics in rheumatic diseases·1986
    Same journal

    Muscle 'contractures' and the 'stiff-man' syndrome.

    Clinics in rheumatic diseases·1986
    Same journal

    Hypophosphatasia.

    Clinics in rheumatic diseases·1986
    Same journal

    Alkaptonuria.

    Clinics in rheumatic diseases·1986
    Same journal

    Diabetes mellitus and rheumatic disease.

    Clinics in rheumatic diseases·1986
    Same journal

    Musculoskeletal manifestations of primary hyperparathyroidism.

    Clinics in rheumatic diseases·1986
    See all related articles

    Area of Science:

    • Genetics
    • Biochemistry
    • Clinical Medicine

    Background:

    • Osteogenesis imperfecta (brittle bone syndrome) is a group of genetic disorders characterized by fragile bones.
    • The primary cause is mutations in genes encoding type I collagen alpha chains.
    • Severe forms lead to significant physical disability and pose clinical management challenges.

    Purpose of the Study:

    • To review the current understanding of the genetic basis of osteogenesis imperfecta.
    • To highlight the advancements in prenatal diagnostic capabilities.
    • To emphasize the ongoing clinical challenges in managing severe cases.

    Main Methods:

    • Literature review of genetic and biochemical studies on osteogenesis imperfecta.
    • Analysis of current clinical practices and outcomes for patients with severe disease.

    Related Experiment Videos

  • Identification of areas for future research.

    • Main Results:

    • Mutations in type I collagen alpha chains are definitively linked to osteogenesis imperfecta.
    • Biochemical advancements have improved the possibility of prenatal diagnosis.
    • Effective clinical management for severe physical disability remains a significant unmet need.

    Conclusions:

    • Genetic mutations in type I collagen are the established cause of brittle bone syndrome.
    • Prenatal diagnosis is becoming more feasible due to biochemical progress.
    • Future research must integrate both clinical and biochemical approaches to improve patient care.